CVS Health Co. (NYSE:CVS) Shares Purchased by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio grew its holdings in CVS Health Co. (NYSE:CVS) by 2.5% during the third quarter, HoldingsChannel reports. The firm owned 635,796 shares of the pharmacy operator’s stock after acquiring an additional 15,746 shares during the period. Public Employees Retirement System of Ohio’s holdings in CVS Health were worth $39,979,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Dynamic Advisor Solutions LLC boosted its position in shares of CVS Health by 15.2% during the 2nd quarter. Dynamic Advisor Solutions LLC now owns 46,558 shares of the pharmacy operator’s stock valued at $2,750,000 after acquiring an additional 6,153 shares during the last quarter. NorthCrest Asset Manangement LLC grew its stake in shares of CVS Health by 0.9% in the 2nd quarter. NorthCrest Asset Manangement LLC now owns 103,751 shares of the pharmacy operator’s stock valued at $6,128,000 after buying an additional 941 shares during the period. V Square Quantitative Management LLC increased its holdings in shares of CVS Health by 4.1% during the 2nd quarter. V Square Quantitative Management LLC now owns 12,950 shares of the pharmacy operator’s stock worth $765,000 after buying an additional 505 shares during the last quarter. ORG Partners LLC raised its position in shares of CVS Health by 11,840.0% during the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 592 shares during the period. Finally, Cornerstone Wealth Management LLC grew its position in CVS Health by 7.6% in the second quarter. Cornerstone Wealth Management LLC now owns 17,174 shares of the pharmacy operator’s stock worth $1,014,000 after acquiring an additional 1,214 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. Royal Bank of Canada reduced their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a report on Tuesday, October 1st. Barclays cut their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research report on Thursday, November 7th. Evercore ISI lifted their price objective on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $70.50.

CVS Health Price Performance

Shares of NYSE:CVS opened at $56.06 on Tuesday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. CVS Health Co. has a 12 month low of $52.71 and a 12 month high of $83.25. The firm has a market capitalization of $70.55 billion, a P/E ratio of 14.23, a P/E/G ratio of 0.95 and a beta of 0.54. The company’s fifty day moving average price is $59.21 and its 200 day moving average price is $58.78.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same period in the prior year, the firm earned $2.21 EPS. The business’s revenue was up 6.3% on a year-over-year basis. As a group, sell-side analysts predict that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.74%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s payout ratio is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.